Rosalba Martino
Research Subjects
Research Interests
Rosalba Martino has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Chirico
Sapienza University of Rome
1 shared publication - Eleonora Capovilla
Istituto Oncologico Veneto IOV – IRCCS, Via Gattamelata, 64, 35128 Padova, Italy
1 shared publication - Fabio Lucidi
Sapienza University of Rome
1 shared publication - Gian Luca De Salvo
Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy
1 shared publication - Leonardo Trentin
Istituto Oncologico Veneto IOV – IRCCS, Via Gattamelata, 64, 35128 Padova, Italy
1 shared publication - Paola Del Bianco
Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy
1 shared publication
Latest Publications
- Open Access
- 5 April 2019
- Published by Springer Nature in BMC Palliative Care
- Vol. 18 (1) , 34
Self-efficacy for coping: utility of the Cancer behavior inventory (Italian) for use in palliative care
Newer models of palliative and supportive cancer care view the person as an active agent in managing physical and psychosocial challenges. Therefore, personal efficacy is an integral part of this model. Due to the lack of instruments in Italian to assess coping self-efficacy, the present study included the translation and validation of the Italian version of the Cancer Behavior Inventory–Brief (CBI-B/I) and an initial analysis of the utility of self-efficacy for coping in an Italian sample of palliative care patients. 216 advanced cancer patients who attended palliative care clinics were enrolled. The CBI-B/I was administered along with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), the Mini Mental Adjustment to Cancer Scale (Mini-MAC), the Cancer Concerns Checklist (CCL), and the Hospital Anxiety and Depression Scale (HADS). The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ratings of functional capacity were completed by physicians. Factor analysis confirmed that the structure of the CBI-B/I was consistent with the English version. Internal consistency reliability and significant correlations with the EORTC QLQ-C30, Mini-MAC, and HADS supported the concurrent validity of the CBI-B/I. Differences in CBI-B/I scores for high versus low levels of the CCL and ECOG-PS supported the clinical utility of the CBI-B/I. The CBI-B/I has strong psychometric properties and represents an important addition to newer model of palliative and supportive care. In order to improve clinical practice, the CBI-B/I could be useful in identifying specific self-efficacy goals for coping in structured psychosocial interventions.
- 5 April 2019
- Published by Springer Nature in BMC Palliative Care
- Vol. 18 (1) , 34
Open AccessSelf-efficacy for coping: utility of the Cancer behavior inventory (Italian) for use in palliative care
Newer models of palliative and supportive cancer care view the person as an active agent in managing physical and psychosocial challenges. Therefore, personal efficacy is an integral part of this model. Due to the lack of instruments in Italian to assess coping self-efficacy, the present study included the translation and validation of the Italian version of the Cancer Behavior Inventory–Brief (CBI-B/I) and an initial analysis of the utility of self-efficacy for coping in an Italian sample of palliative care patients. 216 advanced cancer patients who attended palliative care clinics were enrolled. The CBI-B/I was administered along with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), the Mini Mental Adjustment to Cancer Scale (Mini-MAC), the Cancer Concerns Checklist (CCL), and the Hospital Anxiety and Depression Scale (HADS). The Eastern Cooperative Oncology Group Performance Status (ECOG-PS) ratings of functional capacity were completed by physicians. Factor analysis confirmed that the structure of the CBI-B/I was consistent with the English version. Internal consistency reliability and significant correlations with the EORTC QLQ-C30, Mini-MAC, and HADS supported the concurrent validity of the CBI-B/I. Differences in CBI-B/I scores for high versus low levels of the CCL and ECOG-PS supported the clinical utility of the CBI-B/I. The CBI-B/I has strong psychometric properties and represents an important addition to newer model of palliative and supportive care. In order to improve clinical practice, the CBI-B/I could be useful in identifying specific self-efficacy goals for coping in structured psychosocial interventions.